BioRem Inc. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was CAD 7.31 million compared to CAD 4.58 million a year ago. Net income was CAD 0.761179 million compared to net loss of CAD 0.115394 million a year ago. Basic earnings per share from continuing operations was CAD 0.05 compared to basic loss per share from continuing operations of CAD 0.003 a year ago. Diluted earnings per share from continuing operations was CAD 0.04 compared to diluted loss per share from continuing operations of CAD 0.003 a year ago.
For the nine months, sales was CAD 17.95 million compared to CAD 13.64 million a year ago. Net income was CAD 0.825199 million compared to net loss of CAD 0.286526 million a year ago. Basic earnings per share from continuing operations was CAD 0.05. Diluted earnings per share from continuing operations was CAD 0.04.